FDA recall, , Moderate risk
ARUP Laboratories Apheresis Platelets, PAS, Leukocytes Reduced
Apheresis Platelets, PAS, Leukocytes Reduced were not tested to verify residual white blood cell count and pH testing was not performed.
Recall ended Oct 22, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
ARUP Laboratories, Inc. began a recall of Apheresis Platelets, PAS, Leukocytes Reduced on November 4, 2025, because the products were labeled as leukocytes reduced but were not tested to verify residual white blood cell count and pH testing was not performed. The FDA added the recall to its Enforcement Report on October 22, 2026, and classified it on the same date. The recall involved product distributed in Utah.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, PAS, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- ARUP Laboratories, Inc.
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 100020
- Recall number
- B-0012-2027
All recalls from ARUP Laboratories, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
